2026-06-07 Drugs SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1)
2026-06-05 The Authority SFDA: AI-Powered 'RASID' Service Cuts Controlled Medication Verification Time for Hajj Pilgrims by 98%
2026-06-04 Drugs The SFDA Grants Breakthrough Designation to "ZENBEXUS" for the Treatment of Adult Patients with Multiple Myeloma
